Allan S. Myerson
Massachusetts Institute of Technology
326 Papers
2.8K Citations
Allan S. Myerson is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Crystallization & Nucleation. The author has an hindex of 56, co-authored 313 publications. Previous affiliations of Allan S. Myerson include New York University & Illinois Institute of Technology.
Chat about Author
Papers
•Book
Handbook of industrial crystallization
Allan S. Myerson
- 01 Jan 2002
TL;DR: Solutions and Solution Properties Crystals, Crystal Growth, and Nucleation The Influence of Impurities and Solvents on Crystallization Analysis and Measurement of Crystallisation Utilizing the Population Balance Crystallizer Selection and Design Precipitation Processes Melt and Mixing:Understanding and Modelingcrystallizer mixing andsuspension flow control of crystallization processes Processes Batch and Multi-batchCrystallization:
1.5K
Nucleation of crystals from solution: classical and two-step models.
TL;DR: The shortcomings of classical nucleation theory are discussed and the applicability of the two-step mechanism to both macromolecules and small organic molecules are demonstrated, suggesting that this mechanism may underlie most crystallization processes from solutions.
1K
Polymorphs, Salts, and Cocrystals: What’s in a Name?
Srinivasulu Aitipamula,Rahul Banerjee,Arvind K. Bansal,Kumar Biradha,Miranda L. Cheney,Angshuman Roy Choudhury,Gautam R. Desiraju,Amol G. Dikundwar,Ritesh Dubey,Naga Kiran Duggirala,Preetam P. Ghogale,Soumyajit Ghosh,Pramod Kumar Goswami,N. Rajesh Goud,Ram K. R. Jetti,Piotr H. Karpinski,Poonam Kaushik,Dinesh Kumar,Vineet Kumar,Brian Moulton,Arijit Mukherjee,Gargi Mukherjee,Allan S. Myerson,Vibha Puri,Arunachalam Ramanan,T. Rajamannar,C. Malla Reddy,Naír Rodríguez-Hornedo,Robin D. Rogers,T. N. Guru Row,Palash Sanphui,Ning Shan,Ganesh Shete,Amit Singh,Changquan Calvin Sun,Jennifer A. Swift,Ram Thaimattam,Tejender S. Thakur,Rajesh Kumar Thaper,Sajesh P. Thomas,Srinu Tothadi,Venu R. Vangala,Narayan Variankaval,Peddy Vishweshwar,David R. Weyna,Michael J. Zaworotko +45 more
TL;DR: A discussion of the FDA guidance on regulatory classification of pharmaceutical cocrystals of active pharmaceutical ingredients (APIs) was held in Manesar near Delhi, India, from February 2-4, 2012 as mentioned in this paper.
931
On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system
Andrea Adamo,Rachel L. Beingessner,Mohsen Behnam,Jie Chen,Timothy F. Jamison,Klavs F. Jensen,Jean-Christophe Monbaliu,Allan S. Myerson,Eve Revalor,David R. Snead,Torsten Stelzer,Nopphon Weeranoppanant,Shin Yee Wong,Ping Zhang +13 more
TL;DR: An apparatus roughly the size of a household refrigerator is presented that can synthesize and purify pharmaceuticals under continuous-flow conditions, and the synthesis and formulation of active pharmaceutical ingredients in a compact, reconfigurable manufacturing platform is reported.
End‐to‐End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation
Salvatore Mascia,Patrick L. Heider,Haitao Zhang,Richard Lakerveld,Brahim Benyahia,Paul I. Barton,Richard D. Braatz,Charles L. Cooney,James M. B. Evans,Timothy F. Jamison,Klavs F. Jensen,Allan S. Myerson,Bernhardt L. Trout +12 more
TL;DR: The continuous pilot-scale plant used a novel route that incorporated many advantages of continuous-flow processes to produce active pharmaceutical ingredients and the drug product in one integrated system.